Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL eye solution |
Is a |
Product containing dorzolamide (medicinal product) |
false |
Inferred relationship |
Some |
|
|
Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL eye solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Dorzolamide (substance) |
false |
Inferred relationship |
Some |
|
|
Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL eye solution |
Has manufactured dose form |
Ocular dose form (dose form) |
false |
Inferred relationship |
Some |
|
|
Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL eye solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Dorzolamide hydrochloride |
false |
Inferred relationship |
Some |
|
|
Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL eye solution |
Has manufactured dose form |
Conventional release eye solution (dose form) |
true |
Inferred relationship |
Some |
|
|
Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL eye solution |
Is a |
Product manufactured as ocular dose form (product) |
false |
Inferred relationship |
Some |
|
|
Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL eye solution |
Is a |
Ophthalmic sulfonamide preparation |
false |
Inferred relationship |
Some |
|
|
Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL eye solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Carbonic anhydrase inhibitor |
false |
Inferred relationship |
Some |
|
|
Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL eye solution |
This attribute specifies the numerator unit for the concentration strength of a product. |
mg |
true |
Inferred relationship |
Some |
1 |
|
Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL eye solution |
Has concentration strength numerator value |
20 |
false |
Inferred relationship |
Some |
1 |
|
Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL eye solution |
This attribute specifies the denominator unit for the concentration strength of a product. |
mL |
true |
Inferred relationship |
Some |
1 |
|
Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL eye solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
Dorzolamide hydrochloride |
true |
Inferred relationship |
Some |
1 |
|
Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL eye solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
Dorzolamide (substance) |
true |
Inferred relationship |
Some |
1 |
|
Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL eye solution |
Count of base of active ingredient |
un |
false |
Inferred relationship |
Some |
|
|
Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL eye solution |
Has concentration strength denominator value |
un |
false |
Inferred relationship |
Some |
1 |
|
Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL eye solution |
Plays role |
Antiglaucoma therapeutic role |
false |
Inferred relationship |
Some |
|
|
Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL eye solution |
Is a |
Dorzolamide only product in ocular dose form |
true |
Inferred relationship |
Some |
|
|